Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAQUINAVIR vs SATRALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAQUINAVIR vs SATRALIZUMAB: Safety Overview

Metric SAQUINAVIR SATRALIZUMAB
Total FAERS Reports 792 219
Deaths Reported 57 16
Death Rate 7.2% 7.3%
Hospitalizations 137 108
Average Patient Age 44.3 yrs 51.6 yrs
% Female Patients 27.5% 82.1%
FDA Approval Date Dec 17, 2004 N/A
Manufacturer N/A Genentech, Inc.
Route N/A SUBCUTANEOUS
Marketing Status Discontinued Prescription